Elevated C-Reactive Protein Predicts Myocardial Deterioration

Article

Systemic inflammation has been identified as a risk factor for the development of heart failure in population studies. In the 5-year prospective MESA study, researchers from Johns Hopkins Hospital in Baltimore recorded a baseline nonspecific marker of systemic inflammation, C-reactive protein (CRP).

Systemic inflammation has been identified as a risk factor for the development of heart failure in population studies. In the 5-year prospective MESA study, researchers from Johns Hopkins Hospital in Baltimore recorded a baseline nonspecific marker of systemic inflammation, C-reactive protein (CRP). After controlling for usual coronary and CHF risk factors, including diabetes, coronary disease, hypertension, smoking status, and BMI, a positive correlation between CRP and myocardial functional deterioration on echocardiogram is observed over the follow-up period. CRP is an independent risk factor for myocardial deterioration.

Choi EY et al. High sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the longitudinal multi-ethnic study of atherosclerosis (MESA). Johns Hopkins Hospital, Baltimore. Presented at: ACC 2011; April 3, 2011; New Orleans.

For additional coverage of ACC 2011 >>

 

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.